Inspira Technologies Launches INSPIRA Cardi-ART for Cardiac Arrest
Ticker: IINNW · Form: 6-K · Filed: Jul 30, 2024 · CIK: 1837493
| Field | Detail |
|---|---|
| Company | Inspira Technologies Oxy B.H.N. LTD (IINNW) |
| Form Type | 6-K |
| Filed Date | Jul 30, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: medical-device, product-launch, cardiac-arrest
TL;DR
Inspira launches INSPIRA Cardi-ART to pump oxygen to the brain during cardiac arrest. Big potential if it works.
AI Summary
On July 30, 2024, Inspira Technologies Oxy B.H.N. Ltd. announced the introduction of its INSPIRA Cardi-ART device. This new technology is designed to deliver oxygen to the brain during cardiac arrest events.
Why It Matters
The INSPIRA Cardi-ART aims to improve outcomes for patients experiencing cardiac arrest by ensuring vital oxygen supply to the brain, potentially reducing brain damage.
Risk Assessment
Risk Level: medium — The success and market adoption of a new medical device like the INSPIRA Cardi-ART are subject to regulatory approvals, clinical efficacy, and competitive pressures.
Key Players & Entities
- Inspira Technologies Oxy B.H.N. Ltd. (company) — Registrant
- INSPIRA Cardi-ART (product) — New device introduced
FAQ
What is the primary function of the INSPIRA Cardi-ART?
The INSPIRA Cardi-ART is designed to provide oxygen to the brain during cardiac arrest.
When was the introduction of the INSPIRA Cardi-ART announced?
The introduction was announced on July 30, 2024.
What type of filing is this report?
This is a Form 6-K report of foreign private issuer.
What is the company's principal executive office address?
The principal executive office is located at 2 Ha-Tidhar St. Ra'anana 4366504, Israel.
Does the company file annual reports under Form 20-F or 40-F?
The registrant files annual reports under Form 20-F.
Filing Stats: 308 words · 1 min read · ~1 pages · Grade level 8.8 · Accepted 2024-07-30 16:19:02
Filing Documents
- ea0210269-6k_inspira.htm (6-K) — 11KB
- ea021026901ex99-1_inspira.htm (EX-99.1) — 15KB
- 0001013762-24-002693.txt ( ) — 27KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inspira Technologies Oxy B.H.N. Ltd. Date: July 30, 2024 By: /s/ Dagi Ben-Noon Name: Dagi Ben-Noon Title: Chief Executive Officer 2